Sarepta Therapeutics | SRPT - 债务

金融业

USD 18.32

USD 3.19B

现金及等价物

USD 571.15M

USD 150.1M

USD 2.22B

USD 502.91M

USD 1.04B

USD 13.29M

USD 375.48M

1.37K

EPS每股收益

USD 0.64

股本和储备

USD 1.53B

USD 251.15M

债务利息支出

USD 21.51M

USD 7M

USD 847.62M

USD 1.76B

USD 330.96M

USD 387.96M

USD 13.29M

普通股股本

USD 105.62M

27.27

USD -1.75M

USD 401.3M

销售和管理费用

USD 107.6M

USD 904.27M

贸易债权人

USD 50.98M

应收帐款人

USD 393.8M

	债务	更改		日
Acadia Pharmaceuticals	USD 50.79M		1.39M	2026-03
Agios Pharmaceuticals	USD 35.74M		4.46M	2026-03
Alnylam Pharmaceuticals	USD 2.48B		1.21B	2026-09
Amgen	USD 57.32B		2.72B	2026-03
BioCryst Pharmaceuticals	USD 828.6M		510K	2024-12
Biogen	USD 7.69B		398.3M	2026-09
BioMarin Pharmaceutical	USD 4.2B		2.76B	2026-06
Capricor Therapeutics	USD 3.38M		0	2025-03
Daiichi Sankyo	JPY 500.48B		200B	2026-06
Eli Lilly	USD 54.91B		11.54B	2026-06
Gilead Sciences	USD 26.25B		4.07B	2026-06
Incyte	USD 38.27M		1.16M	2026-06
Insmed	USD 544.86M		180.93M	2026-09
Ionis Pharmaceuticals	USD 1.91B		425.5M	2026-06
Moderna	USD 1.3B		7M	2026-03
Nektar Therapeutics	USD 0		0	2022-06
Neurocrine Biosciences	USD 401.8M		4.4M	2026-06
Novavax	USD 233.31M		4.23M	2024-09
Pfizer	USD 63.19B		536M	2026-06
PTC Therapeutics	USD 2.84B		2.15B	2026-09
Regeneron Pharmaceuticals	USD 2.71B		400K	2026-06
Roche Holding	CHF 33.03B		1.41B	2025-06
Sangamo BioSciences	USD 0		0	2022-06
Sanofi	EUR 23.58B		3.56B	2026-06
Sarepta Therapeutics	USD 1.04B		3.08M	2026-03
Tectonic Therapeutic	USD 876K		115K	2024-12
Ultragenyx Pharmaceutical	USD 36M		2.17M	2025-12
Vertex Pharmaceuticals	USD 1.98B		8.9M	2026-06